![Driving Digital in Biopharma artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts113/v4/2f/b1/06/2fb10634-2b49-5ac6-f68f-dbdeb6ae39e3/mza_17648814836953173237.jpg/100x100bb.jpg)
2022 Life Sciences Tech Trends - The Metaverse Continuum for Biopharma R&D
Driving Digital in Biopharma
English - November 11, 2022 17:55 - 14 minutes - 32.7 MBMedicine Health & Fitness accenture biopharma biopharmaceutical digital technology Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: 2022 Life Sciences Tech Trends Overview
In this episode, Tom Lehmann talks with Accenture’s Ross Wooddisse, Managing Director and Life Sciences R&D Lead in Europe, about the 2022 Life Sciences Technology Vision and what the Metaverse continuum means for Biopharma R&D. They discuss how science turns into medicine, a new generation of digital trial capabilities and the fundamental opportunity for the industry to move from disease management towards risk prediction and disease prevention.